Aligos Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $45.3M | $265.3M | $220.4M |
| FY2021 | $50.6M | $235.4M | $186.8M |
| FY2022 | $42.8M | $146.7M | $81.3M |
| FY2023 | $59.4M | $151.5M | $135.7M |
| FY2024 | $99.1M | $70.1M | $37.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $45.3M | $265.3M | $220.4M |
| FY2021 | $50.6M | $235.4M | $186.8M |
| FY2022 | $42.8M | $146.7M | $81.3M |
| FY2023 | $59.4M | $151.5M | $135.7M |
| FY2024 | $99.1M | $70.1M | $37.0M |